Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,201 INR | +2.83% | +5.71% | +5.58% |
02-02 | Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
01-31 | Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024 |
Evolution of the average Target Price on Ajanta Pharma Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- AJANTPHARM Stock
- AJANTPHARM Stock
- Consensus Ajanta Pharma Limited